Chronic stress is epidemic, and it is killing us. We know that and strive to become healthier. For some people that can be ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

It is most important to maintain a healthy and fit diet. Health experts say that we need nutrients through regular diet.

The creation of a “Make America Healthy Again Commission” has raised concerns over Washington youths' access to medications ...

Brodmann area 22, namely the superior temporal gyrus, had a greater number of abnormally expressed genes in both diseases; moreover, genes that differentiated AD and schizophrenia patients from ...

Upheaval within the brain’s higher order networks could explain psilocybin users’ feelings of profound connection to the ...

Seasonal Affective Disorder (SAD) affects people during winter, yet many are unaware of its impact. Here are some of SAD’s ...

Musk isn't the only high-profile executive using psychedelic drugs. They're growing in popularity among the startup community ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

Months after Massachusetts voters rejected a ballot question that would permit adults to use and grow certain psychedelic drugs, some state lawmakers have begun proposing bills to legalize psilocybin.

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

Tracey Wade outlines several key issues to consider in developing successful early intervention approaches for people with disordered eating ...